Treatment with infliximab may contribute to the development of peripheral neuropathy among the patients with rheumatoid arthritis.

Suppr

超能文献

作者信息

Kotyla Przemyslaw J, Sliwinska-Kotyla Bogna, Kucharz Eugene J

出版信息

Clin Rheumatol. 2007 Sep;26(9):1595-6. doi: 10.1007/s10067-007-0657-3. Epub 2007 Jun 5.

DOI:10.1007/s10067-007-0657-3

PMID:17549580

Abstract

摘要

相似文献

Treatment with infliximab may contribute to the development of peripheral neuropathy among the patients with rheumatoid arthritis.

Clin Rheumatol. 2007 Sep;26(9):1595-6. doi: 10.1007/s10067-007-0657-3. Epub 2007 Jun 5.

Sensory neuropathy revealing necrotizing vasculitis during infliximab therapy for rheumatoid arthritis.在类风湿关节炎英夫利昔单抗治疗期间出现坏死性血管炎的感觉神经病变。

J Rheumatol. 2004 Oct;31(10):2079-81.

Lewis-Sumner syndrome associated with infliximab therapy in rheumatoid arthritis.类风湿关节炎中与英夫利昔单抗治疗相关的刘易斯-萨姆纳综合征

Muscle Nerve. 2008 Oct;38(4):1318-25. doi: 10.1002/mus.21051.

Risk of herpes zoster in patients with rheumatoid arthritis treated with anti-TNF-alpha agents.接受抗TNF-α药物治疗的类风湿关节炎患者发生带状疱疹的风险。

JAMA. 2009 Feb 18;301(7):737-44. doi: 10.1001/jama.2009.146.

Development of new-onset psoriasis in a patient receiving infliximab for treatment of rheumatoid arthritis.一名接受英夫利昔单抗治疗类风湿性关节炎的患者出现了新发银屑病。

Dermatol Online J. 2008 Sep 15;14(9):12.

Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group.英夫利昔单抗与甲氨蝶呤治疗类风湿关节炎。类风湿关节炎联合治疗抗肿瘤坏死因子试验研究组。

N Engl J Med. 2000 Nov 30;343(22):1594-602. doi: 10.1056/NEJM200011303432202.

[Efficacy and adverse reactions of the TNFalpha inhibitor infliximab in rheumatoid arthritis].

Nihon Rinsho. 2013 Jul;71(7):1209-13.

Peripheral Neuropathy Associated With Anti-Tumor Necrosis Factor Therapy: A Case Report and Review of the Literature.抗肿瘤坏死因子治疗相关的周围神经病变：一例病例报告及文献综述

J Clin Rheumatol. 2019 Oct;25(7):e116-e118. doi: 10.1097/RHU.0000000000000720.

Adverse events in patients with rheumatoid arthritis treated with infliximab in daily clinical practice.英夫利昔单抗治疗类风湿关节炎患者在日常临床实践中的不良事件。

Ann Rheum Dis. 2005 Apr;64(4):645-6. doi: 10.1136/ard.2004.028597.

New-onset demyelination induced by infliximab therapy in two rheumatoid arthritis patients.英夫利昔单抗治疗诱发两名类风湿关节炎患者出现新发脱髓鞘病变

Clin Rheumatol. 2006 Nov;25(6):929-33. doi: 10.1007/s10067-005-0097-x.

引用本文的文献

Jak Inhibitors for Treatment of Autoimmune Diseases: Lessons from Systemic Sclerosis and Systemic Lupus Erythematosus.用于治疗自身免疫性疾病的Jak抑制剂：来自系统性硬化症和系统性红斑狼疮的经验教训。

Pharmaceuticals (Basel). 2022 Jul 28;15(8):936. doi: 10.3390/ph15080936.

Tumor necrosis factor alpha inhibitors and demyelinating disease: what is behind it?肿瘤坏死因子α抑制剂与脱髓鞘疾病：其背后的原因是什么？

Reumatologia. 2021;59(2):65-67. doi: 10.5114/reum.2021.105438. Epub 2021 Apr 27.

Thromboembolic Adverse Drug Reactions in Janus Kinase (JAK) Inhibitors: Does the Inhibitor Specificity Play a Role?Janus 激酶（JAK）抑制剂的血栓栓塞性药物不良反应：抑制剂的特异性是否起作用？

Int J Mol Sci. 2021 Feb 28;22(5):2449. doi: 10.3390/ijms22052449.

Clinical Aspects of Janus Kinase (JAK) Inhibitors in the Cardiovascular System in Patients with Rheumatoid Arthritis.类风湿关节炎患者心血管系统中 Janus 激酶（JAK）抑制剂的临床方面。

Int J Mol Sci. 2020 Oct 7;21(19):7390. doi: 10.3390/ijms21197390.

The rheumatoid hand in the light of fluorescence: a diagnostic technique of the future?荧光下的类风湿性手部：未来的诊断技术？

Reumatologia. 2019;57(1):45-49. doi: 10.5114/reum.2019.83239. Epub 2019 Feb 28.

Bimodal Function of Anti-TNF Treatment: Shall We Be Concerned about Anti-TNF Treatment in Patients with Rheumatoid Arthritis and Heart Failure?抗 TNF 治疗的双重作用：我们是否应该关注类风湿关节炎合并心力衰竭患者的抗 TNF 治疗？

Int J Mol Sci. 2018 Jun 12;19(6):1739. doi: 10.3390/ijms19061739.

Letters to the Editor.致编辑的信。

Ochsner J. 2017 Spring;17(1):2-5. doi: 10.1043/1524-5012-17.1.2.

Rheumatoid meningitis associated with infliximab.与英夫利昔单抗相关的类风湿性脑膜炎。

Proc (Bayl Univ Med Cent). 2016 Apr;29(2):204-6. doi: 10.1080/08998280.2016.11929419.

Investigation of effects of two-different treatment modalities on nerve conduction in patients with ankylosing spondylitis.探讨两种不同治疗方式对强直性脊柱炎患者神经传导的影响。

Rheumatol Int. 2012 Feb;32(2):431-4. doi: 10.1007/s00296-010-1677-x. Epub 2010 Dec 1.

A case of spontaneously recovering multifocal motor neuropathy with conduction blocks (MMNCB) during anti-TNF alpha therapy for ankylosing spondylitis.

Clin Rheumatol. 2009 Aug;28(8):993-5. doi: 10.1007/s10067-009-1174-3. Epub 2009 Apr 7.

本文引用的文献

Peripheral neuropathy in two patients with rheumatoid arthritis receiving infliximab treatment.两名接受英夫利昔单抗治疗的类风湿关节炎患者出现周围神经病变。

Clin Rheumatol. 2007 Feb;26(2):258-60. doi: 10.1007/s10067-006-0317-z. Epub 2006 Jul 6.

Demyelination occurring during anti-tumor necrosis factor alpha therapy for inflammatory arthritides.抗肿瘤坏死因子α治疗炎性关节炎期间发生的脱髓鞘病变。

Arthritis Rheum. 2001 Dec;44(12):2862-9. doi: 10.1002/1529-0131(200112)44:12<2862::aid-art474>3.0.co;2-w.

TNF neutralization in MS: results of a randomized, placebo-controlled multicenter study. The Lenercept Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group.肿瘤坏死因子中和治疗多发性硬化症：一项随机、安慰剂对照多中心研究的结果。Lenercept多发性硬化症研究小组及英属哥伦比亚大学多发性硬化症/磁共振成像分析小组。

Neurology. 1999 Aug 11;53(3):457-65.

Tumor necrosis factor identified in multiple sclerosis brain.在多发性硬化症大脑中发现的肿瘤坏死因子。

J Exp Med. 1989 Aug 1;170(2):607-12. doi: 10.1084/jem.170.2.607.

Association between tumor necrosis factor-alpha and disease progression in patients with multiple sclerosis.

N Engl J Med. 1991 Aug 15;325(7):467-72. doi: 10.1056/NEJM199108153250704.

Anti-tumor necrosis factor therapy abrogates autoimmune demyelination.抗肿瘤坏死因子疗法可消除自身免疫性脱髓鞘。

Ann Neurol. 1991 Nov;30(5):694-700. doi: 10.1002/ana.410300510.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验